This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Conflict of Interest  • Medical Education  • Medical Ethics  • Ophthalmology, Other  • Statistics and Research Methods  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Lee M. Jampol, MD; Samuel Packer, MD; Richard P. Mills, MD; Susan H. Day, MD; Paul R. Lichter, MD; for the Council of the American Ophthalmological Society

Arch Ophthalmol. 2009;127(9):1194-1202.

Relationships between physicians and industry including pharmaceutical companies and device manufacturers are being closely scrutinized by the public and the media. These companies can contribute beneficially to patient outcomes by supporting research that improves eye care. However, ethical issues may arise that affect practicing ophthalmologists, researchers, academic faculty, and ophthalmologic organizations. These topics were discussed at a symposium sponsored by the American Ophthalmological Society in May 2008. After this meeting, the council of the society developed this perspective to clarify some of the issues at the interface of industry and ophthalmology. The perspective is intended to provide some guidance to physicians, researchers, and professional societies and to enhance further dialogue.

Author Affiliations: Departments of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (Dr Jampol); North Shore–Long Island Jewish Health System, Great Neck, New York (Dr Packer); University of Washington, Seattle (Dr Mills); California Pacific Medical Center, San Francisco (Dr Day); and University of Michigan, Ann Arbor (Dr Lichter).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?